HK1030545A1 - Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture - Google Patents

Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture

Info

Publication number: HK1030545A1
Authority: HK; Hong Kong
Prior art keywords: vertebral; hormone; parathyroide; risk; reducing
Prior art date: 1998-08-19

Application number

HK01101056A

Other languages

English (en)

Inventor

Janet M Hock

Gregory A Gaich

Willard H Dere

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-19

Filing date

2001-02-14

Publication date

2001-05-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26792729&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1030545(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-02-14 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2001-05-11 Publication of HK1030545A1 publication Critical patent/HK1030545A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Endocrinology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Steroid Compounds (AREA)
Materials For Medical Uses (AREA)

HK01101056A 1998-08-19 2001-02-14 Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture HK1030545A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US9715198P	1998-08-19	1998-08-19
US9974698P	1998-09-10	1998-09-10
PCT/US1999/018961 WO2000010596A1 (en)	1998-08-19	1999-08-19	Method of increasing bone toughness and stiffness and reducing fractures

Publications (1)

Publication Number	Publication Date
HK1030545A1 true HK1030545A1 (en)	2001-05-11

Family

ID=26792729

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
HK01101056A HK1030545A1 (en)	1998-08-19	2001-02-14	Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture
HK07110798.6A HK1102496A1 (en)	1998-08-19	2007-10-04	Hpth(1-34) for use in preventing or reducing the incidence or severity of vertebral and / or non vertebral fracture in a male human
HK16100519.4A HK1212602A1 (zh)	1998-08-19	2016-01-18	增加骨的韌性和硬度和減少骨折的方法

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
HK07110798.6A HK1102496A1 (en)	1998-08-19	2007-10-04	Hpth(1-34) for use in preventing or reducing the incidence or severity of vertebral and / or non vertebral fracture in a male human
HK16100519.4A HK1212602A1 (zh)	1998-08-19	2016-01-18	增加骨的韌性和硬度和減少骨折的方法

Country Status (33)

Country	Link
US (2)	US6977077B1 (uk)
EP (3)	EP1059933B1 (uk)
JP (5)	JP2002523375A (uk)
KR (1)	KR100454207B1 (uk)
CN (1)	CN1205997C (uk)
AR (1)	AR033639A1 (uk)
AT (1)	ATE231000T1 (uk)
AU (1)	AU746277B2 (uk)
BR (1)	BR9909445A (uk)
CA (1)	CA2325371C (uk)
CO (1)	CO5130020A1 (uk)
CY (2)	CY1113343T1 (uk)
CZ (1)	CZ301017B6 (uk)
DE (2)	DE15152726T1 (uk)
DK (4)	DK1769804T3 (uk)
DZ (1)	DZ2873A1 (uk)
EA (1)	EA003362B1 (uk)
ES (4)	ES2393200T3 (uk)
HK (3)	HK1030545A1 (uk)
HR (1)	HRP20000755A2 (uk)
HU (2)	HU1200430D0 (uk)
ID (1)	ID29039A (uk)
IL (2)	IL138829A0 (uk)
MY (1)	MY129227A (uk)
NO (2)	NO323984B1 (uk)
NZ (1)	NZ507056A (uk)
PE (1)	PE20001089A1 (uk)
PL (1)	PL201688B1 (uk)
PT (4)	PT2907522T (uk)
TR (1)	TR200003455T2 (uk)
TW (1)	TW576747B (uk)
UA (1)	UA72205C2 (uk)
WO (1)	WO2000010596A1 (uk)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6770623B1 (en) *	1997-12-09	2004-08-03	Eli Lilly And Company	Stabilized teriparatide solutions
DZ2873A1 (fr) *	1998-08-19	2003-12-15	Lilly Co Eli	Procédé pour augmenter la dureté et la rigidité osseuse.
US20040033950A1 (en) *	2000-09-26	2004-02-19	Hock Janet M.	Method of increasing bone toughness and stiffness and reducing fractures
EP1222465A1 (en) *	1999-09-20	2002-07-17	Eli Lilly And Company	Method for monitoring treatment with a parathyroid hormone
US7247609B2 (en)	2001-12-18	2007-07-24	Universitat Zurich	Growth factor modified protein matrices for tissue engineering
EP1531855A4 (en) *	2002-01-10	2009-07-22	Osteotrophin Llc	TREATMENT OF BONE DISEASES WITH SKELETTAL ANABOLIKA
US8088734B2 (en)	2003-01-21	2012-01-03	Unigene Laboratories Inc.	Oral delivery of peptides
CA2539357A1 (en) *	2003-09-19	2005-03-31	Pfizer Products Inc.	Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
US20060052305A1 (en) *	2004-05-10	2006-03-09	Nastech Pharmaceutical Company Inc.	Method of treating osteoporosis using intranasal parathyroid hormone
US20060189533A1 (en) *	2004-05-10	2006-08-24	Nastech Pharmaceutical Company Inc.	Stable pharmaceutical dosage forms of teriparatide
US20060127320A1 (en) *	2004-05-10	2006-06-15	Nastech Pharmaceutical Company Inc.	Method of delivering parathyroid hormone to a human
CN101151048A (zh) *	2004-05-10	2008-03-26	纳斯泰克制药公司	增强甲状旁腺激素粘膜递送的组合物和方法
CA2566032A1 (en)	2004-05-13	2005-12-01	Alza Corporation	Apparatus and method for transdermal delivery of parathyroid hormone agents
US7648965B2 (en)	2004-05-14	2010-01-19	Unigene Laboratories Inc.	Method for fostering bone formation and preservation
WO2006124062A1 (en) *	2005-05-11	2006-11-23	Unigene Laboratories, Inc.	Method for fostering bone formation and preservation
US20060069021A1 (en) *	2004-08-13	2006-03-30	Nastech Pharmaceutical Company Inc.	Compositions and methods for intranasal administration of inactive analogs of PTH or inactivated preparations of PTH or PTH analogs
US8575101B2 (en)	2005-01-06	2013-11-05	Kuros Biosurgery Ag	Supplemented matrices for the repair of bone fractures
WO2006073711A2 (en) *	2005-01-06	2006-07-13	Kuros Biosurgery Ag	Use of a matrix comprising a contrast agent in soft tissues
US20070173447A1 (en) *	2005-10-25	2007-07-26	Nastech Pharmaceutical Company Inc.	Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
WO2007059470A2 (en) *	2005-11-10	2007-05-24	Board Of Control Of Michigan Technological University	Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US20080051332A1 (en) *	2005-11-18	2008-02-28	Nastech Pharmaceutical Company Inc.	Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
US20080119408A1 (en) *	2006-07-07	2008-05-22	Nastech Pharmaceutical Company Inc.	Pth formulations for intranasal delivery
EP1961765A1 (en) *	2006-12-08	2008-08-27	Zealand Pharma A/S	Truncated PTH peptides with a cyclic conformation
WO2008125655A1 (en)	2007-04-13	2008-10-23	Kuros Biosurgery Ag	Polymeric tissue sealant
US20110137243A1 (en) *	2007-09-06	2011-06-09	Abbott Cardiovascular Systems Inc.	Coating On A Balloon Device
WO2009072119A2 (en) *	2007-12-04	2009-06-11	Ben-Gurion University Of The Negev Research And Development Authority	Amphiphilic peptide matrices for treatment of osteoporosis
WO2009083544A2 (en)	2007-12-28	2009-07-09	Kuros Biosurgery Ag	Pdgf fusion proteins incorporated into fibrin foams
MX335951B (es)	2009-09-09	2016-01-04	Asahi Kasei Pharma Corp	Agente terapeutico/profilactico que contiene pth para la osteoporosis, caracterizado porque la pth se administra una vez a la semana en una dosis unitaria de 100 a 200 unidades.
AU2009356227A1 (en)	2009-12-07	2012-06-21	Michigan Technological University	Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US9295663B2 (en)	2010-07-14	2016-03-29	Abbott Cardiovascular Systems Inc.	Drug coated balloon with in-situ formed drug containing microspheres
WO2012111852A1 (ja) *	2011-02-17	2012-08-23	帝人ファーマ株式会社	椎体骨折治療剤及びその評価方法
WO2012123028A1 (en)	2011-03-16	2012-09-20	Kuros Biosurgery Ag	Pharmaceutical formulation for use in spinal fusion
KR101787956B1 (ko)	2011-06-07	2017-10-18	아사히 가세이 파마 가부시키가이샤	고순도 ｐｔｈ 함유 동결 건조 제제 및 그의 제조 방법
US9700485B2 (en)	2013-04-24	2017-07-11	Corning Incorporated	Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
JP6815407B2 (ja)	2016-02-01	2021-01-20	イーライリリーアンドカンパニー	副甲状腺ホルモン−抗ｒａｎｋｌ抗体融合化合物
JP2020506926A (ja) *	2017-02-01	2020-03-05	ザ・ジョンズ・ホプキンス・ユニバーシティ	副甲状腺ホルモンと変性椎間板疾患の再生
CN110996988A (zh) *	2017-09-22	2020-04-10	旭化成制药株式会社	稳定性优异的含有特立帕肽的液态药物组合物
CN111447943A (zh)	2018-10-29	2020-07-24	旭化成制药株式会社	以按每周2次的频率给予特立帕肽或其盐为特征的骨质疏松症的预防或治疗方法
EP4010360A1 (en)	2019-08-09	2022-06-15	Flagship Pioneering Innovations VI, LLC	Modulators of parathyroid hormone receptor (pthr1)
GB2590692A (en) *	2019-12-24	2021-07-07	Corthotec Ltd	Composition for improved bone fracture healing

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4086196A (en)	1975-03-28	1978-04-25	Armour Pharmaceutical Company	Parathyroid hormone
IL78342A (en)	1985-04-04	1991-06-10	Gen Hospital Corp	Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
DE3935738A1 (de)	1989-10-27	1991-05-08	Forssmann Wolf Georg	Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
US5208041A (en)	1991-05-23	1993-05-04	Allelix Biopharmaceuticals Inc.	Essentially pure human parathyroid hormone
CA2126299C (en)	1994-06-20	2000-12-12	Gordon E. Willick	Parathyroid hormone analogues for the treatment of osteoporosis
JPH0873376A (ja)	1994-09-07	1996-03-19	Asahi Chem Ind Co Ltd	骨粗鬆症治療薬
AU4472896A (en) *	1994-12-19	1996-07-10	Beth Israel Hospital Association, The	Continuous low-dose administration of parathyroid hormone or its agonist
US5747456A (en) *	1994-12-19	1998-05-05	Beth Israel Deaconess Medical Center	Continuous low-dose administration of parathyroid hormone or its agonist
EE9700136A (et) *	1994-12-22	1997-12-15	Astra Aktiebolag	Paratüroidhormooni PTH sisaldav ravimpreparaat inhaleerimiseks
JPH08310965A (ja) *	1995-05-16	1996-11-26	Chugai Pharmaceut Co Ltd	骨癒合促進剤
ZA988030B (en) *	1997-09-09	1999-03-09	Hoffmann La Roche	Fracture healing using pthrp analogs
MY120063A (en)	1997-12-09	2005-08-30	Lilly Co Eli	Stabilized teriparatide solutions
DZ2873A1 (fr)	1998-08-19	2003-12-15	Lilly Co Eli	Procédé pour augmenter la dureté et la rigidité osseuse.
US20040033950A1 (en)	2000-09-26	2004-02-19	Hock Janet M.	Method of increasing bone toughness and stiffness and reducing fractures
US6907597B1 (en)	2000-10-13	2005-06-14	Ati International Srl	Method and apparatus for constructing an executable program in memory
US6967759B2 (en)	2001-12-31	2005-11-22	Texas Instruments Incorporated	Pulse width modulation sequence generation
JP5796714B2 (ja)	2012-01-13	2015-10-21	株式会社リコー	定着装置及び画像形成装置
EP2949301B1 (en)	2014-05-27	2018-04-18	The Procter and Gamble Company	Absorbent core with curved and straight absorbent material areas

1999
- 1999-08-18 DZ DZ990173A patent/DZ2873A1/xx active
- 1999-08-18 AR ARP990104133A patent/AR033639A1/es unknown
- 1999-08-19 TR TR2000/03455T patent/TR200003455T2/xx unknown
- 1999-08-19 DK DK06027055.0T patent/DK1769804T3/da active
- 1999-08-19 EP EP99942350A patent/EP1059933B1/en not_active Revoked
- 1999-08-19 DK DK10180447.4T patent/DK2266598T3/en active
- 1999-08-19 DK DK15152726.4T patent/DK2907522T3/en active
- 1999-08-19 ES ES06027055T patent/ES2393200T3/es not_active Expired - Lifetime
- 1999-08-19 PT PT15152726T patent/PT2907522T/pt unknown
- 1999-08-19 ES ES15152726.4T patent/ES2549551T3/es not_active Expired - Lifetime
- 1999-08-19 WO PCT/US1999/018961 patent/WO2000010596A1/en active IP Right Grant
- 1999-08-19 EP EP10180447.4A patent/EP2266598B1/en not_active Expired - Lifetime
- 1999-08-19 HU HUP1200430 patent/HU1200430D0/hu not_active Application Discontinuation
- 1999-08-19 PT PT06027055T patent/PT1769804E/pt unknown
- 1999-08-19 DK DK99942350T patent/DK1059933T3/da active
- 1999-08-19 IL IL13882999A patent/IL138829A0/xx unknown
- 1999-08-19 CN CNB998083534A patent/CN1205997C/zh not_active Expired - Lifetime
- 1999-08-19 CO CO99052525A patent/CO5130020A1/es unknown
- 1999-08-19 AT AT99942350T patent/ATE231000T1/de not_active IP Right Cessation
- 1999-08-19 BR BR9909445-2A patent/BR9909445A/pt not_active Application Discontinuation
- 1999-08-19 JP JP2000565916A patent/JP2002523375A/ja active Pending
- 1999-08-19 PT PT101804474T patent/PT2266598T/pt unknown
- 1999-08-19 NZ NZ507056A patent/NZ507056A/en not_active IP Right Cessation
- 1999-08-19 EA EA200001015A patent/EA003362B1/ru not_active IP Right Cessation
- 1999-08-19 CA CA002325371A patent/CA2325371C/en not_active Expired - Lifetime
- 1999-08-19 MY MYPI99003553A patent/MY129227A/en unknown
- 1999-08-19 ES ES10180447.4T patent/ES2621653T3/es not_active Expired - Lifetime
- 1999-08-19 KR KR10-2001-7002092A patent/KR100454207B1/ko not_active IP Right Cessation
- 1999-08-19 ES ES99942350T patent/ES2190244T3/es not_active Expired - Lifetime
- 1999-08-19 DE DE15152726.4T patent/DE15152726T1/de active Pending
- 1999-08-19 UA UA2000095457A patent/UA72205C2/uk unknown
- 1999-08-19 PL PL343595A patent/PL201688B1/pl not_active IP Right Cessation
- 1999-08-19 PT PT99942350T patent/PT1059933E/pt unknown
- 1999-08-19 CZ CZ20004134A patent/CZ301017B6/cs not_active IP Right Cessation
- 1999-08-19 ID IDW20010612A patent/ID29039A/id unknown
- 1999-08-19 PE PE1999000839A patent/PE20001089A1/es not_active Application Discontinuation
- 1999-08-19 EP EP15152726.4A patent/EP2907522B1/en not_active Revoked
- 1999-08-19 AU AU55750/99A patent/AU746277B2/en not_active Expired
- 1999-08-19 US US09/647,278 patent/US6977077B1/en not_active Expired - Lifetime
- 1999-08-19 HU HU0101594A patent/HU230697B1/hu unknown
- 1999-08-19 DE DE69904918T patent/DE69904918T2/de not_active Expired - Lifetime
- 1999-10-26 TW TW088114185A patent/TW576747B/zh not_active IP Right Cessation
2000
- 2000-10-03 IL IL138829A patent/IL138829A/en unknown
- 2000-11-06 HR HR20000755A patent/HRP20000755A2/hr not_active Application Discontinuation
- 2000-11-24 NO NO20005947A patent/NO323984B1/no not_active IP Right Cessation
2001
- 2001-02-14 HK HK01101056A patent/HK1030545A1/xx unknown
2005
- 2005-04-05 US US11/098,894 patent/US7163684B2/en not_active Expired - Lifetime
2007
- 2007-06-11 NO NO20072983A patent/NO20072983L/no not_active Application Discontinuation
- 2007-10-04 HK HK07110798.6A patent/HK1102496A1/xx unknown
2010
- 2010-10-29 JP JP2010244314A patent/JP2011021035A/ja not_active Withdrawn
2012
- 2012-11-14 CY CY20121101096T patent/CY1113343T1/el unknown
2014
- 2014-03-25 JP JP2014061763A patent/JP6177718B2/ja not_active Expired - Lifetime
- 2014-10-03 JP JP2014204577A patent/JP2015028065A/ja not_active Withdrawn
2016
- 2016-01-18 HK HK16100519.4A patent/HK1212602A1/zh not_active IP Right Cessation
2017
- 2017-06-26 JP JP2017124301A patent/JP2017190332A/ja not_active Withdrawn
- 2017-10-13 CY CY20171101077T patent/CY1119552T1/el unknown

Also Published As

Publication number	Publication date
NO20005947D0 (no)	2000-11-24
AU746277B2 (en)	2002-04-18
ES2393200T3 (es)	2012-12-19
EP2907522B1 (en)	2017-08-02
ES2190244T3 (es)	2003-07-16
HU230697B1 (hu)	2017-09-28
HUP0101594A2 (hu)	2001-11-28
ID29039A (id)	2001-07-26
DK2907522T3 (en)	2017-10-23
TW576747B (en)	2004-02-21
DK1059933T3 (da)	2003-04-07
CN1205997C (zh)	2005-06-15
PL201688B1 (pl)	2009-04-30
DK1769804T3 (da)	2012-10-15
PT2907522T (pt)	2017-10-23
NO20005947L (no)	2000-11-24
PL343595A1 (en)	2001-08-27
DE15152726T1 (de)	2015-12-10
IL138829A0 (en)	2001-10-31
DZ2873A1 (fr)	2003-12-15
US6977077B1 (en)	2005-12-20
CZ20004134A3 (cs)	2001-08-15
CO5130020A1 (es)	2002-02-27
JP2002523375A (ja)	2002-07-30
DE69904918T2 (de)	2003-11-13
EA003362B1 (ru)	2003-04-24
HUP0101594A3 (en)	2002-01-28
KR20010072763A (ko)	2001-07-31
PT1059933E (pt)	2003-06-30
DE69904918D1 (de)	2003-02-20
CN1308545A (zh)	2001-08-15
JP2015028065A (ja)	2015-02-12
TR200003455T2 (tr)	2001-06-21
JP2014139220A (ja)	2014-07-31
US7163684B2 (en)	2007-01-16
EP1059933B1 (en)	2003-01-15
ES2549551T3 (es)	2017-11-27
HU1200430D0 (hu)	2001-11-28
UA72205C2 (uk)	2005-02-15
NO20072983L (no)	2000-11-24
JP2011021035A (ja)	2011-02-03
ATE231000T1 (de)	2003-02-15
EP1059933A1 (en)	2000-12-20
PT2266598T (pt)	2017-05-02
DK2266598T3 (en)	2017-05-15
MY129227A (en)	2007-03-30
JP2017190332A (ja)	2017-10-19
CY1119552T1 (el)	2018-03-07
AU5575099A (en)	2000-03-14
CA2325371C (en)	2004-08-17
US20050197294A1 (en)	2005-09-08
EP2907522A1 (en)	2015-08-19
HRP20000755A2 (en)	2001-02-28
EA200001015A1 (ru)	2001-02-26
HK1212602A1 (zh)	2016-06-17
IL138829A (en)	2011-01-31
PT1769804E (pt)	2012-11-13
KR100454207B1 (ko)	2004-10-26
AR033639A1 (es)	2004-01-07
NZ507056A (en)	2003-10-31
HK1102496A1 (en)	2007-11-23
CA2325371A1 (en)	2000-03-02
WO2000010596A1 (en)	2000-03-02
CZ301017B6 (cs)	2009-10-14
ES2549551T1 (es)	2015-10-29
PE20001089A1 (es)	2000-11-04
EP2266598B1 (en)	2017-02-22
DK2907522T1 (da)	2015-10-19
JP6177718B2 (ja)	2017-08-09
CY1113343T1 (el)	2016-06-22
NO323984B1 (no)	2007-07-30
BR9909445A (pt)	2000-12-12
ES2621653T3 (es)	2017-07-04
EP2266598A1 (en)	2010-12-29

Publication	Publication Date	Title
HK1030545A1 (en)	2001-05-11	Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture
AU5799099A (en)	2000-03-21	Method and devices for use in bone fixation procedures
PL339449A1 (en)	2000-12-18	Treatment of bone fractures involving the use of pthrp analogues
ZA9510147B (en)	1997-05-29	Hard tissue bone cements and substitutes
EP0767624A4 (en)	1998-09-23	DEVICES AND METHOD FOR PREPARING BONE / TISSUE
GB2356147B (en)	2004-07-07	Bone alignment and fixation device
EP0791338A3 (en)	1997-10-29	Surgical fastener for use in fixing bone fractures
AU2002353044A8 (en)	2003-06-17	System and method for bone fixation
IL143645A0 (en)	2002-04-21	Improved device for the external fixation of bone fractures, in particular ankle fractures
PL339548A1 (en)	2000-12-18	Implant for uniting two fragments of fractured bone
HUP0004313A2 (en)	2001-03-28	Implant for stabilizing a fracture and screw for use in surgery
AU3745700A (en)	2000-10-09	Fastener and method for bone fixation
IL133864A0 (en)	2001-04-30	Combination distraction dental implant and method of use
HK1046378A1 (en)	2003-01-10	Bioactive and osteoporotic bone cement
HUP0001811A3 (en)	2001-02-28	Bone paste and method for preparation thereof
HK1011926A1 (en)	1999-07-23	The use of bisphosphonates in bone surgery
AU3904200A (en)	2000-11-02	Bone fracture fixation clip
GB9421362D0 (en)	1994-12-07	Orthopaedic human bone demonstational aid
EP0779812A4 (en)	1997-09-10	METHOD FOR TREATING OSTEOPOROSIS USING BONE-ACTIVE PHOSPHONATES AND PARATHORMONE
PL321836A1 (en)	1997-12-22	Method of reducing the risk of vertebral bone fracture
HUP9904049A3 (en)	2000-07-28	Growth hormone component and bone anti-resorptive agent in cyclic(coherence)treatment of osteoporosis
EP0691349A3 (en)	1997-09-10	Morphogenetic dimeric proteins of bone origin and their fragments and anologues and pharmaceutical compositions containing them
SI1059933T1 (en)	2003-04-30	Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture
EP1504124A4 (en)	2006-08-30	LDL-RECEPTOR-RELATED PROTEINS 1 AND 2 AND TREATMENT OF BONE OR CANCER DISORDERS
ZA958277B (en)	1996-04-24	The fixation of long bone fractures

Legal Events

Date	Code	Title	Description
2004-12-15	PF	Patent in force